Rockwell Medical (NASDAQ:RMTI – Get Free Report) and STAAR Surgical (NASDAQ:STAA – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.
Institutional & Insider Ownership
23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by company insiders. Comparatively, 39.9% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Risk and Volatility
Rockwell Medical has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rockwell Medical | 1 | 0 | 1 | 0 | 2.00 |
| STAAR Surgical | 3 | 8 | 2 | 0 | 1.92 |
Rockwell Medical currently has a consensus price target of $20.00, indicating a potential upside of 148.14%. STAAR Surgical has a consensus price target of $28.40, indicating a potential upside of 36.41%. Given Rockwell Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Rockwell Medical is more favorable than STAAR Surgical.
Profitability
This table compares Rockwell Medical and STAAR Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Rockwell Medical | -7.33% | -14.03% | -8.90% |
| STAAR Surgical | 1.13% | 9.05% | 6.99% |
Earnings & Valuation
This table compares Rockwell Medical and STAAR Surgical”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rockwell Medical | $69.26 million | 0.47 | -$5.31 million | ($1.34) | -6.01 |
| STAAR Surgical | $239.44 million | 4.36 | -$80.45 million | $0.07 | 297.43 |
Rockwell Medical has higher earnings, but lower revenue than STAAR Surgical. Rockwell Medical is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
STAAR Surgical beats Rockwell Medical on 10 of the 14 factors compared between the two stocks.
About Rockwell Medical
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
About STAAR Surgical
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.
